World Engineering Microorganisms into Powerful Micromachines Market Study 2021: Can Synthetic Biology Foster Bio-Revolution?
Dublin, Dec. 06, 2021 (GLOBE NEWSWIRE) -- The "Engineering Microorganisms into Powerful Micromachines: Can Synthetic Biology Foster Bio-Revolution??" report has been added to ResearchAndMarkets.com's offering.
Engineering Microorganisms into Powerful Micromachines: Can Synthetic Biology Foster Bio-Revolution?
This report highlights the importance of SynBio in the design and creation of biological entities that do not exist in nature or reengineer existing biological systems to develop products like medicines, chemicals, ingredients, and advanced materials to revolutionize the way we live and build a sustainable economy.
Summary
Achieving global goals such as mass-scale food production and sustainable low-cost manufacturing methods is the need of the hour. Synthetic Biology (SynBio) is a field of science that has grown over the last two decades to emerge as a mature area in biological engineering with its potential to reduce the costs of biological production methods and improve the global food supply. It also can be crucial to create patient-centric drugs and promote precision medicine for better health outcomes.
SynBio overview and its key applications across industries, use-cases and major stakeholders in each industry, the noise created in the media, VC investment trends, real-world innovation use cases and examples related to the implementation of SynBio, trends in patent filings and grants, and the future potential of SynBio.
Scope
Technology Decoding: presents the technology overview, key features, market drivers, major applications, and a market map with potential use cases and popular players (startups as well as enterprises).
Media Analysis: highlights the technology presentation from the media perspective - major news, and lauds from the social media promoting the technology. Also, includes mentions of the technology from company annual and other filings.
Investment Radar: outlines the venture capital funding trends with some of the popular deals, the most funded startups, and notable investors and accelerators pumping millions into the technology growth.
Innovation Explorer: introduces game-changing company innovations with a spotlight on startups. Select corporate-startup partnerships inclined at future product developments are also mentioned.
IP Landscaping: provides a broad-level analysis of the trends in patent filings and grants, priority countries, and key patent filers in the technology.
The Road Ahead: summarizes the drivers and challenges, use cases that can become successful with business leaders, potential applications in new horizons, and the outlook of the technology.
Key Topics Covered:
1. Technology Decoding: overview
2. Media Analysis: News publication trends, Thought leadership, Social media traction, Company filings
3. Investment Radar: VC investment trends, Top countries by most deals, Top funded startups, Most active investors and accelerators
4. Innovation Explorer: Key innovators: startups under spotlight and major enterprises in action
5 IP Landscaping: IP Filing trends
6 Road Ahead: Drivers and challenges, Emerging concepts, Potential use cases for business leaders, Futuristic industry applications, Outlook
Companies Mentioned
10X Genomics
23&me
4DMT
AB InBev
Abbvie
Absci
ADM
Adrestia
AgBiome
Agilent
Agrigenetics
Agrimetis
Agrivida
Air Protein
Alexandria Real Estate Equity Inc
Allonnia
Amgen
Amunix
Amyris
Andes
Antheia
Apeel Biosciences
AquaBounty Technologies
ARCH Venture Capital
Arkema
Arsenal Bio
Artios
Artiva
Arzeda
Asimov
AstraZeneca
Atlas Venture Inc
Atomwise
AzarGen Biotechnologies
Azitra
Bactolife
BASF
BASF Venture Capital
Bayer
Beam Therapeutics
Beijing Biocytogen
Benson Hill
BEOnChip
BGI
Biogen
Biomason
Bio-Rad
Biota
Bolt Therapeutics
Bolt Threads
Bota Biosciences
BP
Bristol Meyers
Bruker
Calysta
Calyxt
Cargill
Caribou Biosciences
Celgene
Cellarity
Cellectis
CG Oncology
China National Chemical Corp
Chromatin
CinderBio
Clara Foods
Clariant
Coca Cola
Codexis
Conagen
Corbion
Corteva
Cysbio
Danaher
Decode Genetics
Dell
Dow
DSM
Dupont
Editas Medicine
Editas Medicine
eGenesis
eGenesis
Elevate Bio
ElevateBio
Eligo Bioscience
EnginZyme
Evolva Holdings
Evolve Biosystems
Evonik
ExxonMobil
Flagship Pioneering
Future Fields
Future Meat
GE Research
Genecis
Genedata
Genome Company
Genomic Vision
Genopole
Gent Bio
Gingko Bioworks
GlycosBio
Google
GreenLight Biosciences
GRO Biosciences
Hera BioLabs
Hexagon Bio
Hitachi
Hookipa Biotech
Hoxton Farms
Huawei
Human Genome Sciences
Humane Genomics
IBM
ICRISAT
igenebio
Illumina
Impossible Foods
Inari
Inc.
Industrial Microbes
Ineos
Inscripta
Insitro
GlaxoSmithKline
Integrated DNA Technologies
J&J
JLabs
Johnson & Johnson
Just Foods
Kaiima
Keygene
Kheiron
Khosla Ventures
Kinnva
Kite Pharma
Kriya Therapeutics
L'Oreal
L'oreal
Lab Central
Lanzatech
Leaps by Bayer
Light Bio
Lonza
Lululemon
Lux Capital
Lygos
Mammoth Biosciences
Manus Bio
Meatable
Merck
Merck
Michelin
Microsoft
Modern Meadow
Monsanto
Mosa Meat
Motif
Mussel Polymers
Nature's Sources
Nebula Genomics
New Age Meats
Nike
Nomad Foods
Novartis
Novartis Ventures
Novo Nordisk Foundation
Novoloop
Novozymes
NRGene
Omega Therapeutics
Orbimed Ventures
Origin Bio
Outpace
P&G
Pandion Therapeutics
Pepsico
Perfect Day
Perkin Elmer
Pfizer
Pfizer
Pfizer Ventures
Photanol
Pivot Bio
Plant Sensory Systems
Polaris Private Equity
Poseida Therapeutics
Precigen
Precision Biosciences
rBio
Recombinetics Inc.
Recursion
Redefine Meats
Regeneron Pharmaceuticals
Reliance Industries Limited
Resilience
Roche
S.V Health Ventures
SABIC
Saint-Gobain
Samsung
Sanatech Seeds
Sangamo
Sankyo Co Ltd
Sanofi
Scribe Therapeutics
Seattle Genetics
Second Genome
SentiBio
Shape Therapeutics
Shell
Shenyang Tonglian
Sherlock Biosciences
Sinopec
Siolta Therapeutics
Soffinova Ventures
Sonoma
Sony
Spiber
Startup Health
Stratcode
Sumitomo
Syngenta
Synlogic
Synthace
Synthego
Synthekine
Tata Chemicals
Terravia
TeselaGen
Thermo Fischer
Thermo Fisher Scientific
Triton Algae Innovations
Twist Biosciences
Unilever
Unilever
Upside Foods
Verily
Verve Therapeutics
Viridos
Zymergen
Visolis
Vivet Therapeutics
WarpBio
Werewolf Therapeutics
Y Combinator
Yara
Zydus Cadilla
Zymergen
ZymoChem
For more information about this report visit https://www.researchandmarkets.com/r/a8p2vl
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900